TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/4/20 06:00 | 12/2/20 | YMAB | Y-Mabs Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moller-San Pedro Claus Juan | NY | DO | CEO | S.m | -2,561 | 51.21 | 0 | -50 | -7 | 625 | I | ||||||||||||||
5/15/20 16:16 | 5/13/20 | YMAB | Y-Mabs Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moller-San Pedro Claus Juan | NY | DO | CEO | S.m | -7,310 | 36.55 | 0 | -200 | -23 | 675 | I | ||||||||||||||
3/19/20 17:00 | 3/17/20 | YMAB | Y-Mabs Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moller-San Pedro Claus Juan | NY | DO | CEO | P | 33 | 17.22 | 0 | 2 | 0 | 875 | I | ||||||||||||||
9/25/18 16:37 | 9/25/18 | YMAB | Y-Mabs Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Juan Moller San Pedro Claus | NY | DO | CEO | P | 500 | 16.00 | 0 | 31 | 2 | 1,746 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |